The symptomatic and neuroprotective activities of the selective BChE inhibitor UW‐MD‐95 were analyzed in the pharmacological mouse model of Alzheimer's disease induced by ICV injection of oligomerized Aβ25‐35. Here, BCHE is linked to Alzheimer disease.